Kateryna Rudnieva

Postgraduate student

Description of the field of scientific research:

Antibiotic resistance and antibiotic therapy; ESKAPE-pathogens; healthcare-associated infections; biofilm as the most common variant of bacteria in the macroorganism; laboratory diagnosis of HAIs; infection control.  

List of duties:

Kateryna is a bacteriologist and a postgraduate student at the Department of microbiology and parasitology with the basics of immunology at Bogomolets National Medical University. She is interested in the problem of antibiotic resistance in hospital strains of microorganisms and ways to overcome it and prevent its spread. In addition, she promotes microbiology knowledge among clinicians and collaborates with the infection control team.

Professional experience:

From 2014 to 2023, Olga worked in the Clinical diagnostic laboratory at the Kyiv Regional Clinical Hospital. From 2023 to the present, she has been an assistant at the Department of microbiology and parasitology with the basics of immunology at the Bogomolets National Medical University.

Keywords:

• Science popularization

• Teaching

• Medicine

• Public speaking

• Healthcare

Basic scientific publications:

• Case report: Azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in Ukraine

  Read

  Kryzhevskyi, V., Strokous, V., Lifshyts, Y., Rybianets, Y., Oberniak, A., Krikunov, A., Iungin, O., Potochilova, V., Rudnieva, K., Petakh, P., Kamyshnyi, A., & Moshynets, O. Frontiers in Medicine 2023

  Role: Author

• Therapeutic Potential of an Azithromycin-Colistin Combination against XDR K. pneumoniae in a 3D Collagen-Based In Vitro Wound Model of a Biofilm Infection

  Read

  Moshynets, O. V., Baranovskyi, T. P., Iungin, O. S., Krikunov, A. A., Potochilova, V. V., Rudnieva, K. L., Potters, G., & Pokholenko, I. (2023). Therapeutic potential of an azithromycin-colistin combination against XDR K. Pneumoniae in a 3D collagen-based in vitro wound model of a biofilm infection. Antibiotics, 12(2), 293.

  Role: Author

• Azithromycin possesses biofilm–inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia

  Read

  Moshynets, O. V., Baranovskyi, T. P., Cameron, S., Iungin, O. S., Pokholenko, I., Jerdan, R., Kamyshnyi, A., Krikunov, A. A., Potochilova, V. V., Rudnieva, K. L., & Spiers, A. J. (2022). Azithromycin possesses biofilm–inhibitory activity and potentiates non-bactericidal Colistin Methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia. PLOS ONE, 17(7).

  Role: Author